CNS leukemia at diagnosis was defined as >5 mononuclear leukocytes/mm3 and blast cells in a cytospin preparation of cerebrospinalfluid (CSF), or the presence of clinical signs of CNS involvement . Patients who presented with CNS involvement were only eligible for the HRgroup and received additional CNS directed therapy.